Skip to main content
logo
AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India flag India · Delayed Price · Currency is INR
8,957.50
+64.00 (0.72%)
Aug 4, 2025, 3:29 PM IST

AstraZeneca Pharma India Revenue

In the fiscal year ending March 31, 2025, AstraZeneca Pharma India had annual revenue of 17.16B INR with 32.48% growth. AstraZeneca Pharma India had revenue of 4.80B in the quarter ending March 31, 2025, with 25.39% growth.

Revenue
17.16B
Revenue Growth
+32.48%
P/S Ratio
12.95
Revenue / Employee
21.40M
Employees
802
Market Cap
222.33B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202517.16B4.21B32.48%
Mar 31, 202412.96B2.93B29.17%
Mar 31, 202310.03B1.97B24.50%
Mar 31, 20228.06B-79.60M-0.98%
Mar 31, 20218.14B-182.50M-2.19%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.77B
Divi's Laboratories93.60B
Cipla274.80B
Mankind Pharma129.10B
Apollo Hospitals Enterprise217.94B
Zydus Lifesciences232.42B
Fortis Healthcare77.86B
Aurobindo Pharma317.24B
Revenue Rankings

AstraZeneca Pharma India News

More News